Surface design of nanocarriers: Key to more efficient oral drug delivery systems

As nanocarriers (NCs) can improve the solubility of drugs, prevent their degradation by gastrointestinal (GI) enzymes and promote their transport across the mucus gel layer and absorption membrane, the oral bioavailability of these drugs can be substantially enhanced. All these properties of NCs inc...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Advances in colloid and interface science 2023-03, Vol.313, p.102848-102848, Article 102848
Hauptverfasser: Spleis, Helen, Sandmeier, Matthias, Claus, Victor, Bernkop-Schnürch, Andreas
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 102848
container_issue
container_start_page 102848
container_title Advances in colloid and interface science
container_volume 313
creator Spleis, Helen
Sandmeier, Matthias
Claus, Victor
Bernkop-Schnürch, Andreas
description As nanocarriers (NCs) can improve the solubility of drugs, prevent their degradation by gastrointestinal (GI) enzymes and promote their transport across the mucus gel layer and absorption membrane, the oral bioavailability of these drugs can be substantially enhanced. All these properties of NCs including self-emulsifying drug delivery systems (SEDDS), solid lipid nanoparticles (SLNs), nanostructured lipid carriers (NLCs), liposomes, polymeric nanoparticles, inorganic nanoparticles and polymeric micelles depend mainly on their surface chemistry. In particular, interaction with food, digestive enzymes, bile salts and electrolytes, diffusion behaviour across the mucus gel layer and fate on the absorption membrane are determined by their surface. Bioinert surfaces limiting interactions with gastrointestinal fluid and content as well as with mucus, adhesive surfaces providing an intimate contact with the GI mucosa and absorption enhancing surfaces can be designed. Furthermore, charge converting surfaces shifting their zeta potential from negative to positive directly at the absorption membrane and surfaces providing a targeted drug release are advantageous. In addition to these passive surfaces, even active surfaces cleaving mucus glycoproteins on their way through the mucus gel layer can be created. Within this review, we provide an overview on these different surfaces and discuss their impact on the performance of NCs in the GI tract. [Display omitted] •The fate of oral NCs (SEDDS, SLN, NLC, liposomes, polymeric/inorganic nanoparticles) depends on their surface chemistry.•Bioinert surfaces limit interactions with GI content and mucus guaranteeing that NCs can reach the absorption membrane.•Adhesive surfaces provide an intimate contact with the GI mucosa and a prolonged residence time.•Absorption enhancing surfaces guarantee an improved drug permeation of the epithelial cell layer.•Surfaces that shift their zeta potential from negative to positive at the absorption membrane improve cellular uptake.
doi_str_mv 10.1016/j.cis.2023.102848
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2776516968</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0001868623000155</els_id><sourcerecordid>2776516968</sourcerecordid><originalsourceid>FETCH-LOGICAL-c396t-5ef8d378afce1db41fe1fc4afaa1ee443d3f4f8b78423e175696f77ade43af3f3</originalsourceid><addsrcrecordid>eNp9kE1LAzEQhoMotlZ_gBfJ0cvWZLO7SfUkxS8sKKjnkCaTkrK7qcluYf-9Ka0ehYFh4HlfmAehS0qmlNDqZj3VLk5zkrN056IQR2hMBWcZ4zk_RmNCCM1EJaoROotxnc685OUpGrGKC5JmjN4_-mCVBmwgulWLvcWtar1WITgI8Ra_woA7jxsfAIO1TjtoO-yDqrEJ_SrlareFMOA4xA6aeI5OrKojXBz2BH09PnzOn7PF29PL_H6RaTaruqwEKwzjQlkN1CwLaoFaXSirFAUoCmaYLaxYclHkDCgvq1llOVcGCqYss2yCrve9m-C_e4idbFzUUNeqBd9HmXNelTSlRELpHtXBxxjAyk1wjQqDpETuRMq1TCLlTqTci0yZq0N9v2zA_CV-zSXgbg9AenKbXMm4U6PBuAC6k8a7f-p_ABFehLg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2776516968</pqid></control><display><type>article</type><title>Surface design of nanocarriers: Key to more efficient oral drug delivery systems</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Spleis, Helen ; Sandmeier, Matthias ; Claus, Victor ; Bernkop-Schnürch, Andreas</creator><creatorcontrib>Spleis, Helen ; Sandmeier, Matthias ; Claus, Victor ; Bernkop-Schnürch, Andreas</creatorcontrib><description>As nanocarriers (NCs) can improve the solubility of drugs, prevent their degradation by gastrointestinal (GI) enzymes and promote their transport across the mucus gel layer and absorption membrane, the oral bioavailability of these drugs can be substantially enhanced. All these properties of NCs including self-emulsifying drug delivery systems (SEDDS), solid lipid nanoparticles (SLNs), nanostructured lipid carriers (NLCs), liposomes, polymeric nanoparticles, inorganic nanoparticles and polymeric micelles depend mainly on their surface chemistry. In particular, interaction with food, digestive enzymes, bile salts and electrolytes, diffusion behaviour across the mucus gel layer and fate on the absorption membrane are determined by their surface. Bioinert surfaces limiting interactions with gastrointestinal fluid and content as well as with mucus, adhesive surfaces providing an intimate contact with the GI mucosa and absorption enhancing surfaces can be designed. Furthermore, charge converting surfaces shifting their zeta potential from negative to positive directly at the absorption membrane and surfaces providing a targeted drug release are advantageous. In addition to these passive surfaces, even active surfaces cleaving mucus glycoproteins on their way through the mucus gel layer can be created. Within this review, we provide an overview on these different surfaces and discuss their impact on the performance of NCs in the GI tract. [Display omitted] •The fate of oral NCs (SEDDS, SLN, NLC, liposomes, polymeric/inorganic nanoparticles) depends on their surface chemistry.•Bioinert surfaces limit interactions with GI content and mucus guaranteeing that NCs can reach the absorption membrane.•Adhesive surfaces provide an intimate contact with the GI mucosa and a prolonged residence time.•Absorption enhancing surfaces guarantee an improved drug permeation of the epithelial cell layer.•Surfaces that shift their zeta potential from negative to positive at the absorption membrane improve cellular uptake.</description><identifier>ISSN: 0001-8686</identifier><identifier>EISSN: 1873-3727</identifier><identifier>DOI: 10.1016/j.cis.2023.102848</identifier><identifier>PMID: 36780780</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Absorption enhancement ; Administration, Oral ; Biological Availability ; Drug Carriers - chemistry ; Drug Delivery Systems ; Gastrointestinal Tract - metabolism ; Nanocarriers ; Nanoparticles ; Nanoparticles - chemistry ; Oral drug delivery ; Surface decoration</subject><ispartof>Advances in colloid and interface science, 2023-03, Vol.313, p.102848-102848, Article 102848</ispartof><rights>2023 The Authors</rights><rights>Copyright © 2023 The Authors. Published by Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c396t-5ef8d378afce1db41fe1fc4afaa1ee443d3f4f8b78423e175696f77ade43af3f3</citedby><cites>FETCH-LOGICAL-c396t-5ef8d378afce1db41fe1fc4afaa1ee443d3f4f8b78423e175696f77ade43af3f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.cis.2023.102848$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36780780$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Spleis, Helen</creatorcontrib><creatorcontrib>Sandmeier, Matthias</creatorcontrib><creatorcontrib>Claus, Victor</creatorcontrib><creatorcontrib>Bernkop-Schnürch, Andreas</creatorcontrib><title>Surface design of nanocarriers: Key to more efficient oral drug delivery systems</title><title>Advances in colloid and interface science</title><addtitle>Adv Colloid Interface Sci</addtitle><description>As nanocarriers (NCs) can improve the solubility of drugs, prevent their degradation by gastrointestinal (GI) enzymes and promote their transport across the mucus gel layer and absorption membrane, the oral bioavailability of these drugs can be substantially enhanced. All these properties of NCs including self-emulsifying drug delivery systems (SEDDS), solid lipid nanoparticles (SLNs), nanostructured lipid carriers (NLCs), liposomes, polymeric nanoparticles, inorganic nanoparticles and polymeric micelles depend mainly on their surface chemistry. In particular, interaction with food, digestive enzymes, bile salts and electrolytes, diffusion behaviour across the mucus gel layer and fate on the absorption membrane are determined by their surface. Bioinert surfaces limiting interactions with gastrointestinal fluid and content as well as with mucus, adhesive surfaces providing an intimate contact with the GI mucosa and absorption enhancing surfaces can be designed. Furthermore, charge converting surfaces shifting their zeta potential from negative to positive directly at the absorption membrane and surfaces providing a targeted drug release are advantageous. In addition to these passive surfaces, even active surfaces cleaving mucus glycoproteins on their way through the mucus gel layer can be created. Within this review, we provide an overview on these different surfaces and discuss their impact on the performance of NCs in the GI tract. [Display omitted] •The fate of oral NCs (SEDDS, SLN, NLC, liposomes, polymeric/inorganic nanoparticles) depends on their surface chemistry.•Bioinert surfaces limit interactions with GI content and mucus guaranteeing that NCs can reach the absorption membrane.•Adhesive surfaces provide an intimate contact with the GI mucosa and a prolonged residence time.•Absorption enhancing surfaces guarantee an improved drug permeation of the epithelial cell layer.•Surfaces that shift their zeta potential from negative to positive at the absorption membrane improve cellular uptake.</description><subject>Absorption enhancement</subject><subject>Administration, Oral</subject><subject>Biological Availability</subject><subject>Drug Carriers - chemistry</subject><subject>Drug Delivery Systems</subject><subject>Gastrointestinal Tract - metabolism</subject><subject>Nanocarriers</subject><subject>Nanoparticles</subject><subject>Nanoparticles - chemistry</subject><subject>Oral drug delivery</subject><subject>Surface decoration</subject><issn>0001-8686</issn><issn>1873-3727</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1LAzEQhoMotlZ_gBfJ0cvWZLO7SfUkxS8sKKjnkCaTkrK7qcluYf-9Ka0ehYFh4HlfmAehS0qmlNDqZj3VLk5zkrN056IQR2hMBWcZ4zk_RmNCCM1EJaoROotxnc685OUpGrGKC5JmjN4_-mCVBmwgulWLvcWtar1WITgI8Ra_woA7jxsfAIO1TjtoO-yDqrEJ_SrlareFMOA4xA6aeI5OrKojXBz2BH09PnzOn7PF29PL_H6RaTaruqwEKwzjQlkN1CwLaoFaXSirFAUoCmaYLaxYclHkDCgvq1llOVcGCqYss2yCrve9m-C_e4idbFzUUNeqBd9HmXNelTSlRELpHtXBxxjAyk1wjQqDpETuRMq1TCLlTqTci0yZq0N9v2zA_CV-zSXgbg9AenKbXMm4U6PBuAC6k8a7f-p_ABFehLg</recordid><startdate>202303</startdate><enddate>202303</enddate><creator>Spleis, Helen</creator><creator>Sandmeier, Matthias</creator><creator>Claus, Victor</creator><creator>Bernkop-Schnürch, Andreas</creator><general>Elsevier B.V</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202303</creationdate><title>Surface design of nanocarriers: Key to more efficient oral drug delivery systems</title><author>Spleis, Helen ; Sandmeier, Matthias ; Claus, Victor ; Bernkop-Schnürch, Andreas</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c396t-5ef8d378afce1db41fe1fc4afaa1ee443d3f4f8b78423e175696f77ade43af3f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Absorption enhancement</topic><topic>Administration, Oral</topic><topic>Biological Availability</topic><topic>Drug Carriers - chemistry</topic><topic>Drug Delivery Systems</topic><topic>Gastrointestinal Tract - metabolism</topic><topic>Nanocarriers</topic><topic>Nanoparticles</topic><topic>Nanoparticles - chemistry</topic><topic>Oral drug delivery</topic><topic>Surface decoration</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Spleis, Helen</creatorcontrib><creatorcontrib>Sandmeier, Matthias</creatorcontrib><creatorcontrib>Claus, Victor</creatorcontrib><creatorcontrib>Bernkop-Schnürch, Andreas</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Advances in colloid and interface science</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Spleis, Helen</au><au>Sandmeier, Matthias</au><au>Claus, Victor</au><au>Bernkop-Schnürch, Andreas</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Surface design of nanocarriers: Key to more efficient oral drug delivery systems</atitle><jtitle>Advances in colloid and interface science</jtitle><addtitle>Adv Colloid Interface Sci</addtitle><date>2023-03</date><risdate>2023</risdate><volume>313</volume><spage>102848</spage><epage>102848</epage><pages>102848-102848</pages><artnum>102848</artnum><issn>0001-8686</issn><eissn>1873-3727</eissn><abstract>As nanocarriers (NCs) can improve the solubility of drugs, prevent their degradation by gastrointestinal (GI) enzymes and promote their transport across the mucus gel layer and absorption membrane, the oral bioavailability of these drugs can be substantially enhanced. All these properties of NCs including self-emulsifying drug delivery systems (SEDDS), solid lipid nanoparticles (SLNs), nanostructured lipid carriers (NLCs), liposomes, polymeric nanoparticles, inorganic nanoparticles and polymeric micelles depend mainly on their surface chemistry. In particular, interaction with food, digestive enzymes, bile salts and electrolytes, diffusion behaviour across the mucus gel layer and fate on the absorption membrane are determined by their surface. Bioinert surfaces limiting interactions with gastrointestinal fluid and content as well as with mucus, adhesive surfaces providing an intimate contact with the GI mucosa and absorption enhancing surfaces can be designed. Furthermore, charge converting surfaces shifting their zeta potential from negative to positive directly at the absorption membrane and surfaces providing a targeted drug release are advantageous. In addition to these passive surfaces, even active surfaces cleaving mucus glycoproteins on their way through the mucus gel layer can be created. Within this review, we provide an overview on these different surfaces and discuss their impact on the performance of NCs in the GI tract. [Display omitted] •The fate of oral NCs (SEDDS, SLN, NLC, liposomes, polymeric/inorganic nanoparticles) depends on their surface chemistry.•Bioinert surfaces limit interactions with GI content and mucus guaranteeing that NCs can reach the absorption membrane.•Adhesive surfaces provide an intimate contact with the GI mucosa and a prolonged residence time.•Absorption enhancing surfaces guarantee an improved drug permeation of the epithelial cell layer.•Surfaces that shift their zeta potential from negative to positive at the absorption membrane improve cellular uptake.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>36780780</pmid><doi>10.1016/j.cis.2023.102848</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0001-8686
ispartof Advances in colloid and interface science, 2023-03, Vol.313, p.102848-102848, Article 102848
issn 0001-8686
1873-3727
language eng
recordid cdi_proquest_miscellaneous_2776516968
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Absorption enhancement
Administration, Oral
Biological Availability
Drug Carriers - chemistry
Drug Delivery Systems
Gastrointestinal Tract - metabolism
Nanocarriers
Nanoparticles
Nanoparticles - chemistry
Oral drug delivery
Surface decoration
title Surface design of nanocarriers: Key to more efficient oral drug delivery systems
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T04%3A28%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Surface%20design%20of%20nanocarriers:%20Key%20to%20more%20efficient%20oral%20drug%20delivery%20systems&rft.jtitle=Advances%20in%20colloid%20and%20interface%20science&rft.au=Spleis,%20Helen&rft.date=2023-03&rft.volume=313&rft.spage=102848&rft.epage=102848&rft.pages=102848-102848&rft.artnum=102848&rft.issn=0001-8686&rft.eissn=1873-3727&rft_id=info:doi/10.1016/j.cis.2023.102848&rft_dat=%3Cproquest_cross%3E2776516968%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2776516968&rft_id=info:pmid/36780780&rft_els_id=S0001868623000155&rfr_iscdi=true